Sort
21,453 grants matching “tuberculosis”
Novel Pathogen Associated Cancers (PQ12)
$722,856Denise A. Galloway · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
INTERNATIONAL CLINICAL STUDIES SUPPORT CENTER
$722,798Family Health International · N01 · FY2000 · AI
New drugs for non-tuberculous mycobacterial (NTM) lung disease in patients with cystic fibrosis
$722,728Thomas Dick · Hackensack University Medical Center · U19 · FY2021 · AI
Heme and hemoglobin utilization by Mycobacterium tuberculosis
$722,705Michael Niederweis · University Of Alabama At Birmingham · R01 · FY2019 · AI
Marshallese: Alternate Surveillance for COVID-19 in a Unique Population
$722,487Ka'imi Alohilani Sinclair · Washington State University · R01 · FY2021 · MD
Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood
$722,477Zhen Huang · Tulane University Of Louisiana · R01 · FY2025 · AI
CELL WALL OF M TUBERCULOSIS: FOCUS FOR DRUG DISCOVERY
$722,338Colorado State University-Fort Collins · P01 · FY2001 · AI
Precision immunoprofiling to reveal diagnostic biomarkers of latent TB infection
$722,295Ryan C Bailey · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites
$722,155Robert H Gilman · Johns Hopkins University · R01 · FY2020 · AI
Emergence of bedaquiline, pretomanid and linezolid resistance after implementation of new drug-resistant tuberculosis regimens in South Africa
$722,084Barun Mathema · Columbia University Health Sciences · R01 · FY2025 · AI
Development and Testing of New Tuberculosis Vaccines
$721,686Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2010 · AI
Guinea pig model for TB vaccine evaluations
$721,424Colorado State University-Fort Collins · R01 · FY2005 · AI
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. tuberculosi
$721,289Philip C Hopewell · University Of California, San Francisco · R01 · FY2012 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine
$721,271Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
$721,258Michael R Knowles · Univ Of North Carolina Chapel Hill · U54 · FY2019 · HL
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
$721,199David R Sherman · University Of Washington · R01 · FY2023 · AI
Membrane Protein Complexes in the M. Tuberculosis Divisome: Structures and Interactions
$721,194Yan-Yan Hu · Florida State University · R01 · FY2025 · AI
Inhaled Large Porous Particles for Treatment of MDR-TB
$721,165Harvard University · U01 · FY2005 · AI
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
$721,114Eric R Houpt · University Of Virginia · R01 · FY2021 · HL
Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP
$720,969Christopher J Lyon · Tulane University Of Louisiana · R01 · FY2024 · HD
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network Study
$720,951Neel Rajnikant Gandhi · Emory University · R01 · FY2019 · AI
Post-TB epigenetic scars' impact on long-term inflammation, immunity and mortality
$720,939Andrew R Dinardo · Baylor College Of Medicine · R01 · FY2025 · AI
Molecular Imaging for Pulmonary Infections and Inflammation
$720,392Sanjay Jain · Johns Hopkins University · R01 · FY2017 · HL
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
$720,290Shabaana A. Khader · Washington University · R01 · FY2021 · AI
Antigen export in M. tuberculosis evasion of CD4 T cells
$720,090Joel D. Ernst · New York University School Of Medicine · R01 · FY2017 · AI